JUVARIS BIO THERAPEUTICS INC in Pleasanton, California
Company Description:
juvaris biotherapeutics, located in pleasanton, california, is developing therapeutic vaccines for cancer and chronic infectious diseases using its novel technology platform of cationic lipids and non-coding dna complexes.
Services Offered:
Biotherapeutics
Juvaris
Juvaris Biotherapeutics
Technology
Juvaris Biotherapeutics Inc
Biotherapeutics Inc
Complexes
Technology Platform
Company
Appointed
Studies
Platform
Pre-clinical
Technologies
Web Results:
- Lewis T. "Rusty" Williams,...
- contact ussite map Press Releases Press Releases Archive Papers Presentations Industry News Lewis T. "Rusty" Williams, M.D., Ph.D. Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc. Pleasanton, CA - June 6, 2007 Juvaris BioTherapeutics, a private company, today announced the appoin...
- Juvaris Biotherapeutics, Inc. Terms of Use
- contact ussite map Terms of Use Terms of Use By using this site you acknowledge that Juvaris BioTherapeutics, Inc. is providing the material for informational purposes only and that neither Juvaris BioTherapeutics, Inc. nor their agents, affiliates, partners, or licensors are providing the materials...
- Juvaris Biotherapeutics, Inc. About Us Board of Directors
- DHTML Menu By Milonic JavaScript contact ussite map Overview Management Team Board of Directors Contact Us Board of Directors Thomas P. Monath, M.D., (Kleiner Perkins Caufield & Byers) Michael Ross, Ph.D., (SV Life Sciences) Lewis T. "Rusty" Williams, M.D., Ph.D., (Five Prime Therapeutics, Inc.)...
- Juvaris Biotherapeutics, Inc. About Us Management Team
- contact ussite map Overview Management Team Board of Directors Contact Us Management Team Grant E. Pickering, President and Chief Executive Officer Kimberlee Gonzaga, CPA, Chief Financial Officer Grant E. Pickering President and Chief Executive Officer In the first quarter of 2008, Mr. Pickering was...
- Presentations
- contact ussite map Press Releases Press Releases Archive Papers Presentations Industry News Presentations Infectious Diseases Society of America (IDSA) - IDSA 2008 Annual Meeting Adjuvanting of Fluzone with JVRS-100 Enhances H1N1, H3N2, and B Influenza Specific Humoral Responses and Increases the Fr...
Business Information:
In Business Since: | 2001 |
Business Sector: | Residential, Commercial |